Idt Australia Limited. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Idt Australia Limited. with three other
companies in this sector in AUSTRALIA :
Immutep Ltd
(2020
sales of 13.94 million Australian Dollars [US$10.76 million]
of which 99%
was Cancer Immunotherapy),
Pharmaxis Ltd
(12.55 million Australian Dollars [US$9.69 million]
of which 56%
was Mannitol), and
Cellmid Limited
(7.48 million Australian Dollars [US$5.78 million]
of which 79%
was Advangen Japan).
Sales Analysis.
Idt Australia Limited. reported sales of A$14.17 million (US$10.94 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 16.8%
versus 2019, when the company's sales were A$12.13 million.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Idt Australia Limited. had sales
of A$15.72 million.